Teva Is Latest To Be Hit With DOJ Suit Over Charity Copays

Government claims Teva’s payments to two foundations to cover Copaxone copays violated Anti-Kickback statute. Teva is bucking settlement trend in DOJ’s industrywide investigation of sponsor ties to charitable foundations.

WASHINGTON, DC - MARCH 2018: Headquarters of the U.S. Justice Department. Art Deco aluminum torcheres at doorway. Renamed the Robert F. Kennedy Department of Justice Building in 2001.
Department of Justice sues Teva over charity copayments for Copaxone • Source: Shutterstock

Teva Pharmaceutical Industries Ltd. would apparently rather fight than settle US Department of Justice claims that charity copayments for its multiple sclerosis drug Capaxone constitute illegal kickbacks.

More from Legal & IP

More from Pink Sheet